Financial Performance - The company's operating revenue for Q1 2022 was ¥257,889,942.36, representing a 31.35% increase compared to ¥196,335,886.00 in the same period last year[4] - Net profit attributable to shareholders was ¥68,837,886.38, up 33.58% from ¥51,532,054.43 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥67,103,847.65, reflecting a 33.71% increase from ¥50,184,657.21 in the previous year[4] - Operating profit for the quarter was ¥82,643,519.25, representing a year-on-year increase of 34.4% from ¥61,442,743.98[32] - The net profit for the current period is 68,837,886.38, compared to 51,532,054.43 in the previous period, representing a growth of approximately 33.5%[35] - Basic earnings per share increased to 0.1637 from 0.1429, reflecting a rise of about 17.5%[35] Cash Flow - The company's cash flow from operating activities showed a net outflow of ¥25,565,492.63, a significant decrease of 243.49% compared to a net inflow of ¥17,817,167.60 in the same period last year[4] - Cash inflow from operating activities totaled 111,051,731.17, up from 104,546,329.66, indicating an increase of approximately 6.4%[39] - Cash outflow from operating activities rose to 136,617,223.80 from 86,729,162.06, resulting in a net cash flow from operating activities of -25,565,492.63, compared to 17,817,167.60 in the previous period[39] - The net increase in cash and cash equivalents for the current period was 102,426,479.43, compared to a decrease of -23,649,155.33 in the previous period[42] - The ending balance of cash and cash equivalents reached 303,024,322.61, up from 158,090,558.38, indicating a growth of approximately 91.5%[42] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,499,796,542.20, an increase of 5.43% from ¥1,422,613,681.07 at the end of the previous year[4] - Total liabilities amounted to ¥154,620,823.62, up from ¥147,569,613.39, reflecting a rise of 4.3%[24] - Non-current assets totaled ¥578,619,908.22, up from ¥526,091,085.17, showing a growth of 10%[24] - Cash and cash equivalents at the end of the period totaled ¥303,024,322.61, up from ¥200,597,843.18 at the beginning of the year, reflecting a 50.9% increase[24] Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,073[12] - The largest shareholder, Huabang Life Health Co., Ltd., holds 44.51% of shares, totaling 187,216,000 shares[12] - The second-largest shareholder, Zibo Kaisheng Investment Management Center, holds 6.79% of shares, totaling 28,571,200 shares[12] - The company has a total of 364,305,348 shares, with 360,640,000 shares remaining under lock-up conditions[19] - The total number of shares held by the top ten shareholders includes significant stakes from various investment firms and individuals, indicating strong institutional support[12] Operational Developments - The company’s technology center was recognized as a national enterprise technology center in 2021[20] - The company is constructing a new production base in Weifang, which officially commenced on February 12, 2022[20] Other Expenses - The company reported a significant increase in sales expenses by 119.00% to ¥258,000, attributed to higher export business costs[7] - Other operating expenses increased by 196.43% to ¥95,140, primarily due to a donation of ¥1,000,000 to a charity for epidemic prevention[10] Share Issuance and Restrictions - The company has no new shares issued during the reporting period, maintaining the same number of restricted shares[16] - The company plans to lift restrictions on certain shares on September 27, 2022, and September 27, 2024, for various shareholders[16] - The company has not reported any changes in the number of restricted shares during the current period[19] Comprehensive Income - The company reported a total comprehensive income of 68,837,886.38, which is the same as the net profit, indicating no other comprehensive income items for the period[35] Audit Status - The company has not undergone an audit for the first quarter report[43]
凯盛新材(301069) - 2022 Q1 - 季度财报